MAP2K6 is related to the lymph node status of bladder cancer.[42] In addition, targeted down-regulation of MAP2K6 can inhibit the proliferation of esophageal adenocarcinoma cells.[43] MAP2K6 was high expression in LIHC tissues, and the protein expression was consistent. The gene discussed is MAP2K6; the disease is urinary bladder carcinoma.